Comparison Can-Fite Biopharma (CANF) with Competitors
Can-Fite Biopharma (CANF) industry is Biotechnology.
Operating Margin
CANF-2489.00%
Industry-2055.25%
Upside-433.75%
Debt-to-Equity
CANF1.27%
Industry28.27%
Upside-95.51%
P/E
CANF-1.15
Industry-20.52
Upside+1936.27%
Forward P/E
CANF2.97
Industry16.33
Upside-81.84%
P/S
CANF17.56
Industry10.01
Upside+75.36%
P/B
CANF1.26
Industry5.15
Upside-75.58%